Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

  

Search in our Online Store
Drug Delivery
Filter     Order     Display # 
Date Item Title
03 Aug 2006 Biodel Inc. Raises $21 Million in Series B Financing; Top-Tier Healthcare Investors Provide Funding for Phase 3 Clinical Development of Viaject(TM) Rapid Acting Insulin for Type 1 and 2 Diabetes
03 Aug 2006 Celtic Pharma Notes Progress By IDEA AG
02 Aug 2006 MAP Pharmaceuticals Initiates Phase 2 Clinical Trial in Pediatric and Adolescent Patients With Asthma
02 Aug 2006 Columbia Laboratories Completes Enrollment in Pivotal Phase III Study of Prochieve 8% to Prevent Preterm Birth
02 Aug 2006 NeurogesX Receives Confirmation of Transacin Eligibility for EU Centralized Market Submission; Centralized Procedure Enables Pan European Filing
24 Jul 2006 Phosphagenics commences Phase I clinical trial for its transdermal insulin delivery platform TPM-02/Insulin
20 Jul 2006 Foamix's Betamethasone Foam Demonstrates High Efficacy in Psoriasis Treatment and 85% Better Usability Than Cream in Phase I/II Study
20 Jul 2006 Exelon Patch, the First Transdermal Therapy for Alzheimer's Disease, May Provide Promising New Approach to Treatment of Dementia
19 Jul 2006 Emisphere Announces New Multi-Product Research Collaboration Agreement with Roche
18 Jul 2006 Alnylam and INEX Accelerate Collaboration on Systemic Delivery of RNAi Therapeutics; Positive Results for Systemic RNAi Support Advancement to Next Phase of Collaboration
17 Jul 2006 Aegis Therapeutics Announces Successful Human Clinical Study Results for Intravail(R
13 Jul 2006 Abraxis BioScience Receives Milestone Payment from Taiho Pharmaceutical Co. for the Initiation of the First Clinical Trial for ABRAXANE in Japan
13 Jul 2006 Nastech Pharmaceutical Company Receives FDA Communication Concerning Calcitonin-Salmon Nasal Spray
12 Jul 2006 LAB International Announces Positive Fentanyl Phase IIa Results
06 Jul 2006 Elan Signs License Agreement with Abbott for Elan's Proprietary NanoCrystal(R) Technology; To Develop a Single Fixed-Dose Combination of TriCor(R) and Crestor(R) for High Cholesterol Patients
05 Jul 2006 NovaDel Announces Filing of NDA for the Zensana(TM) (Ondansetron HCl) Oral Spray
03 Jul 2006 SCHWARZ PHARMA Filed Application for Neupro in Advanced Parkinson's Disease in EU
01 Jul 2006 Hana Biosciences Submits Zensana(TM) (ondansetron HCl) Oral Spray New Drug Application (NDA) to the U.S. Food and Drug Administration
01 Jul 2006 Phosphagenics receives ethics approval for Phase I clinical trials of its transdermal insulin delivery product
01 Jul 2006 BioAlliance Pharma Announces Preliminary Results of its Doxorubicin Transdrug(R) Phase I/II Clinical Trial for Primary Liver Cancer
30 Jun 2006 SkyePharma Reacquires European Rights for DepoBupivacaine(TM)
30 Jun 2006 Cephalon Receives Approvable Letter for FENTORA(TM) (fentanyl buccal tablet) for Management of Breakthrough Pain in Patients with Cancer
30 Jun 2006 Cipher submits NDA for once-daily TRAMADOL formulation
27 Jun 2006 Nastech's Parathyroid Hormone (PTH1-34) Nasal Spray Demonstrated Similar Exposure Levels to Approved Injectable Product in Phase I Study in the Elderly
21 Jun 2006 ConjuChem Successfully Completes Patient Enrollment of its Phase II Trial of DAC(TM):GRF for Treatment of HIV Lipodystrophy
15 Jun 2006 Cipher Provides Update On Regulatory Path For CIP-TRAMADOL ER
13 Jun 2006 Lab International Initiates Enrollment In Phase IIb Fentanyl Taifun® Trial
13 Jun 2006 Oramed Pharmaceuticals Combats Diabetes with Oral Insulin
11 Jun 2006 Study Demonstrated Once-Weekly Exenatide LAR Improved Glucose Control in Patients with Type 2 Diabetes
11 Jun 2006 Data on AIR Inhaled Insulin System Presented at American Diabetes Association Meeting
10 Jun 2006 BioDelivery Sciences Announces Promising Results of Meeting with FDA on Emezine(R)
06 Jun 2006 Nastech Enters Into Supply Agreement with Procter & Gamble for Parathyroid Hormone (PTH1-34) Nasal Spray
06 Jun 2006 Alexza Initiates AZ-001 Phase IIb Clinical Trial in Patients With Migraine Headaches
06 Jun 2006 Wyeth and Progenics Pharmaceuticals Announce Development Plans for Methylnalatrexone; Treatment Platform Comprising Three Formulations Targets Opioid-Induced Bowel Dysfunction and Post-Operative Bowel Dysfunction
06 Jun 2006 SR Pharma plc Announces a Key Technical Breakthrough With its Lyophilized (Dry Powder) Liposomal-Based siRNA Formulation
06 Jun 2006 Data from CT-2106 Clinical Trial Presented at American Society of Clinical Oncology Meeting
06 Jun 2006 Lilly and Alkermes Complete Patient Enrollment for Phase 3 Safety Study for Inhaled Insulin for the Treatment of Diabetes
06 Jun 2006 Celator Pharmaceuticals Presents Positive Results From Phase I Study for CPX-1 at American Society for Clinical Oncology Meeting
05 Jun 2006 Data from XYOTAX(TM) STELLAR Trials Presented at 2006 Meeting of American Society of Clinical Oncology
05 Jun 2006 Three Studies Confirm Activity of ABRAXANE As First-Line Treatment in Non-Small Cell Lung Cancer and Show Higher Tumor Response Rates Than Current Standard of Care
02 Jun 2006 Halozyme Therapeutics Presents Preclinical and Pharmacokinetic Data on the Subcutaneous Delivery of Antibodies With Enhanze Technology at the 2006 IBC Antibody Conference
02 Jun 2006 BioMarin and Alliant Announce FDA Approval of Orapred ODT
01 Jun 2006 Cell Therapeutics, Inc. (CTI) and FDA Agree on NDA Filing Strategy for XYOTAX(TM)
30 May 2006 Phase II Clinical Trial of NeoPharm's LE-SN38 Initiated by NCI CALGB in Patients with Metastatic Colorectal Cancer; First Patients Treated
27 May 2006 Translational Research Develops Intranasal Formulation of Granisetron, Antiemetic Agent
26 May 2006 Altea Therapeutics Commences Phase 1 Clinical Trials of a Novel Fentanyl Citrate Transdermal Patch Designed for the Safe and Rapid Management of Moderate to Severe Chronic Pain
26 May 2006 Antipodean Pharmaceuticals Initiates Phase 2 Trial in Parkinson's Disease
25 May 2006 Phosphagenics announces positive preclinical trial results for its transdermal insulin formulation
25 May 2006 Positive Study Results for DAYTRANATM(methylphenidate transdermal system) Presented at a Major Medical Meeting
24 May 2006 Javelin Enrolls First Patient in Pivotal Phase III Study of Rylomine(TM)
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 Next > End >>
Results 251 - 300 of 411

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Toll-Like Receptor (TLR) Agonists & Antagonists

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics